Fundz

Jade Biosciences Appoints Brad Dahms as Chief Financial Officer

PUBLIC · JBIOJul 01, 2025

Position

Chief Financial Officer

Company

Jade Biosciences

Brad Dahms
brad.dahms@jadebiosciences.com
WalthamInformation TechnologyBiotechnologyHealthcareHealth CareTherapeutics

Description

Jade Biosciences, Inc. has appointed Brad Dahms as their new Chief Financial Officer. With extensive experience in biotech and finance, he is expected to be a valuable asset as the company moves forward with its growth plans.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Jade Biosciences, and when

A new leader at Jade Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Jade Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Jade Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Jade Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Jade Biosciences

Location

Waltham, Massachusetts, United States

About

Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE-003, an undisclosed antibody discovery program, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Jade Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Andrew
Likely contact at this company
••••••••@••••••••

See Andrew's verified email →

Lori
Senior decision-maker at this company
••••••••@••••••••

See Lori's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Jade Biosciences's next move

Learn about Strategic plan

Jade Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.